Skip to main content
Clinical Trials/NL-OMON55985
NL-OMON55985
Recruiting
Not Applicable

Procalcitonin-guided treatment regarding antibiotic use for acute COPD exacerbations: a prospective randomised controlled trial - PRECISION study

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD flare-up
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
693
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- COPD, according to GOLD 2018 definition
  • \- Hospitalization because of severe acute exacerbation of COPD
  • \- Post\-bronchodilator FEV1/FVC \< 0,70 and FEV1% \< 80%pred. within last 5 years
  • or a lung function within 2 months after the index admission that meets these
  • \- At least 40 years of age
  • \- Smokers or ex\-smokers with \> 10 packyears
  • \- Written informed consent
  • \- Start of symptoms no more than 7 days before admission
  • \- Presence of at least 2 major symptoms of the modified Anthonisen
  • criteria (acute deterioration

Exclusion Criteria

  • \- Indication for ICU and or non\-invasive ventilation \< 72h of admission
  • \- Pneumonia, radiologically confirmed
  • \- Infection at another site and/or sepsis according to the SIRS criteria
  • (with tachycardia and
  • tachypnea not being caused by the exacerbation).
  • \- COPD before age 40\.
  • \- Asthma, without presence of COPD.
  • o Patients with COPD , with or without a history of asthma (in
  • childhood or as an adolescent)
  • will NOT be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials